Many middle-income countries are left out of the deal, widening a gulf in access to critical medicines. Many middle-income countries are left out of the deal, widening a gulf in access to critical medicines. Acquired Immune Deficiency Syndrome, Medicine and Health, Prices (Fares, Fees and Rates), Generic Brands and Products, Drugs (Pharmaceuticals), Developing Countries, Intellectual Property, Inventions and Patents, Epidemics, lenacapavir, Gilead Sciences Inc, Africa, Argentina, Baluchistan (Pakistan), Brazil, China, Colombia NYT > Science
Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries
